These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
176 related articles for article (PubMed ID: 34885092)
1. Clinical Response to Anti-CD47 Immunotherapy Is Associated with Rapid Reduction of Exhausted Bystander CD4 Jiang TT; Kruglov O; Lin GHY; Minic A; Jordan K; Uger RA; Wong M; Shou Y; Akilov OE Cancers (Basel); 2021 Nov; 13(23):. PubMed ID: 34885092 [TBL] [Abstract][Full Text] [Related]
2. The pivotal role of cytotoxic NK cells in mediating the therapeutic effect of anti-CD47 therapy in mycosis fungoides. Kruglov O; Johnson LDS; Minic A; Jordan K; Uger RA; Wong M; Sievers EL; Shou Y; Akilov OE Cancer Immunol Immunother; 2022 Apr; 71(4):919-932. PubMed ID: 34519839 [TBL] [Abstract][Full Text] [Related]
3. Intralesional TTI-621, a novel biologic targeting the innate immune checkpoint CD47, in patients with relapsed or refractory mycosis fungoides or Sézary syndrome: a multicentre, phase 1 study. Querfeld C; Thompson JA; Taylor MH; DeSimone JA; Zain JM; Shustov AR; Johns C; McCann S; Lin GHY; Petrova PS; Uger RA; Molloy N; Shou Y; Akilov OE Lancet Haematol; 2021 Nov; 8(11):e808-e817. PubMed ID: 34627593 [TBL] [Abstract][Full Text] [Related]
4. Primary cutaneous T-cell lymphoma (mycosis fungoides and Sézary syndrome): part I. Diagnosis: clinical and histopathologic features and new molecular and biologic markers. Jawed SI; Myskowski PL; Horwitz S; Moskowitz A; Querfeld C J Am Acad Dermatol; 2014 Feb; 70(2):205.e1-16; quiz 221-2. PubMed ID: 24438969 [TBL] [Abstract][Full Text] [Related]
5. Low-Dose Intralesional Recombinant Interferon-α2b in the Treatment of Mycosis Fungoides. Hu JK; Carlson K; Girardi M Yale J Biol Med; 2020 Mar; 93(1):41-44. PubMed ID: 32226334 [TBL] [Abstract][Full Text] [Related]
6. Membrane expression of NK receptors CD160 and CD158k contributes to delineate a unique CD4+ T-lymphocyte subset in normal and mycosis fungoides skin. Sako N; Schiavon V; Bounfour T; Dessirier V; Ortonne N; Olive D; Ram-Wolff C; Michel L; Sicard H; Marie-Cardine A; Bagot M; Bensussan A; Schmitt C Cytometry A; 2014 Oct; 85(10):869-82. PubMed ID: 25044837 [TBL] [Abstract][Full Text] [Related]
7. Rapidly progressive tumor stage mycosis fungoides: A case report from Syria. Melhem Y; Hussein Al-Janabi M; Mansour M; Suleman H; Al-Shehabi Z Ann Med Surg (Lond); 2022 Dec; 84():104834. PubMed ID: 36582887 [TBL] [Abstract][Full Text] [Related]
8. Progression of mycosis fungoides occurs through divergence of tumor immunophenotype by differential expression of HLA-DR. Murray D; McMurray JL; Eldershaw S; Pearce H; Davies N; Scarisbrick JJ; Moss P Blood Adv; 2019 Feb; 3(4):519-530. PubMed ID: 30770361 [TBL] [Abstract][Full Text] [Related]
9. [Transformed juvenile-onset mycosis fungoides: treatment by bone marrow transplantation with graft-versus-lymphoma effect]. Carrié E; Buzyn A; Fraitag S; Hermine O; Bodemer C Ann Dermatol Venereol; 2007 May; 134(5 Pt 1):471-6. PubMed ID: 17507848 [TBL] [Abstract][Full Text] [Related]
10. O6-alkylguanine-DNA alkyltransferase in cutaneous T-cell lymphoma: implications for treatment with alkylating agents. Dolan ME; McRae BL; Ferries-Rowe E; Belanich M; van Seventer GA; Guitart J; Pezen D; Kuzel TM; Yarosh DB Clin Cancer Res; 1999 Aug; 5(8):2059-64. PubMed ID: 10473086 [TBL] [Abstract][Full Text] [Related]
12. Erythrodermic CD4/CD8 Double-Negative Mycosis Fungoides: A Case Report. Alnasser MA; AlKhawajah NM; AlQadri NG; Shadid AM; Alsaif FM Case Rep Oncol; 2021; 14(1):256-261. PubMed ID: 33776713 [TBL] [Abstract][Full Text] [Related]
13. Mycosis fungoides and Sézary syndrome: focus on the current treatment scenario. Sanches JA; Cury-Martins J; Abreu RM; Miyashiro D; Pereira J An Bras Dermatol; 2021; 96(4):458-471. PubMed ID: 34053802 [TBL] [Abstract][Full Text] [Related]
14. Expression of the CD4+ cell-specific chemoattractant interleukin-16 in mycosis fungoides. Blaschke V; Reich K; Middel P; Letschert M; Sachse F; Harwix S; Neumann C J Invest Dermatol; 1999 Oct; 113(4):658-63. PubMed ID: 10504456 [TBL] [Abstract][Full Text] [Related]
15. IL32 is progressively expressed in mycosis fungoides independent of helper T-cell 2 and helper T-cell 9 polarization. Ohmatsu H; Humme D; Gulati N; Gonzalez J; Möbs M; Suárez-Fariñas M; Cardinale I; Mitsui H; Guttman-Yassky E; Sterry W; Krueger JG Cancer Immunol Res; 2014 Sep; 2(9):890-900. PubMed ID: 24938282 [TBL] [Abstract][Full Text] [Related]
16. Dual-Positive CD4/CD8 Primary Cutaneous Peripheral T-Cell Lymphoma Previously Classified as Mycosis Fungoides a Tumor D'Emblée. Raychaudhuri S; Rahvar M; Jedrych J; Karunamurthy A; Kruglov O; Rakfal S; Kane K; Akilov OE Am J Dermatopathol; 2018 Nov; 40(11):836-840. PubMed ID: 29794483 [TBL] [Abstract][Full Text] [Related]
17. Mycosis fungoides and the Sézary syndrome: pathology, staging, and treatment. Hoppe RT; Wood GS; Abel EA Curr Probl Cancer; 1990; 14(6):293-371. PubMed ID: 2245651 [TBL] [Abstract][Full Text] [Related]
18. CD4/CD8 double-negative epidermotropic cutaneous T-cell lymphoma: an immunohistochemical variant of mycosis fungoides. Hodak E; David M; Maron L; Aviram A; Kaganovsky E; Feinmesser M J Am Acad Dermatol; 2006 Aug; 55(2):276-84. PubMed ID: 16844512 [TBL] [Abstract][Full Text] [Related]
19. Mycosis fungoides bullosa: a case report and review of the literature. Kneitz H; Bröcker EB; Becker JC J Med Case Rep; 2010 Mar; 4():78. PubMed ID: 20196875 [TBL] [Abstract][Full Text] [Related]
20. Erythrodermic mycosis fungoides with large cell transformation: An unusual and complicated case. Lombardi CV; Glosser LD; Hopper W; Veria S; Awad MT; Garg A SAGE Open Med Case Rep; 2022; 10():2050313X221131163. PubMed ID: 36313267 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]